Indonesia Colorectal Cancer Diagnostics Market to 2032

Overview

The Indonesia Colorectal Cancer Diagnostics Market is expected to reach a 58.66 USD Million by 2032 and is projected to grow at a CAGR of 10.38% from 2025 to 2032.

Revenue, 2024 (USD Million)
33.68
Forecast, 2032 (USD Million)
58.66
CAGR, 2024 - 2032
10.38%
Report Coverage
Indonesia

Indonesia Colorectal Cancer Diagnostics Market 2018-2032 USD Million

Indonesia Colorectal Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 33.68 USD Million
  • Projected Market Size (2032): 58.66 USD Million
  • CAGR (2025-2032): 10.38%

Key Findings of Indonesia Colorectal Cancer Diagnostics Market

  • The Indonesia Colorectal Cancer Diagnostics Market was valued at 33.68 USD Million in 2024.
  • The Indonesia Colorectal Cancer Diagnostics Market is likely to grow at a CAGR of 10.38% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Instruments in Product Type Segment accounted for the largest share of the market with a revenue of 24.01 USD Million
  • The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 13.41% during the forecast period from 2024 to 2032.

Indonesia Colorectal Cancer Diagnostics Market Scope

Indonesia Colorectal Cancer Diagnostics Market Segmentation & Scope
Test Type
  • Others
  • Biopsy
  • Tumor Markers
  • Imaging Test
  • Blood Test
  • Stool Examination
Cancer Stages
  • Stage 0
  • Stage I
  • Stage II
  • Stage IV
  • Stage III
Cancer Type
  • Others
  • Carcinoid Tumors
  • Gastrointestinal Stromal Tumors
  • Colorectal Lymphoma
  • Adenocarcinoma
Age Group
  • Pediatric
  • Adults
  • Geriatric
End User
  • Others
  • Academic Institutes
  • Ambulatory Surgical Centers
  • Cancer Research Centers
  • Diagnostic Centers
  • Hospitals
Product Type
  • Consumables & Accessories
  • Instruments

Indonesia Colorectal Cancer Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Million
Market Value in 2024 33.68 USD Million
Market Value in 2032 58.66 USD Million
CAGR (2025-2032) 10.38%
Historic Data 2016-2023
Market Segments Covered Test Type,Cancer Stages,Cancer Type,Age Group,End User,Product Type

Regional Insights:

  • Leading Market (2024-2032): Indonesia, leading in terms of revenue 33.68 USD Million in 2024
    • Key Country: Indonesia, leading in terms of revenue with value of 33.68 USD Million in 2024.

Segments and Scope

  • Indonesia Colorectal Cancer Diagnostics Market to 2032, By Test Type
    • Stool Examination is the largest segment in Indonesia Colorectal Cancer Diagnostics Market to 2032 with a revenue of 14.67 USD Million in the year 2024.
    • Stool Examination is the Fastest growing segment in Indonesia Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 12.58 % in forecast period 2025-2032.
  • Indonesia Colorectal Cancer Diagnostics Market to 2032, By Cancer Stages
    • Stage III is the largest segment in Indonesia Colorectal Cancer Diagnostics Market to 2032 with a revenue of 15.27 USD Million in the year 2024.
    • Stage III is the Fastest growing segment in Indonesia Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 12.83 % in forecast period 2025-2032.
  • Indonesia Colorectal Cancer Diagnostics Market to 2032, By Cancer Type
    • Adenocarcinoma is the largest segment in Indonesia Colorectal Cancer Diagnostics Market to 2032 with a revenue of 21.59 USD Million in the year 2024.
    • Adenocarcinoma is the Fastest growing segment in Indonesia Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 11.24 % in forecast period 2025-2032.
  • Indonesia Colorectal Cancer Diagnostics Market to 2032, By Age Group
    • Geriatric is the largest segment in Indonesia Colorectal Cancer Diagnostics Market to 2032 with a revenue of 16.81 USD Million in the year 2024.
    • Geriatric is the Fastest growing segment in Indonesia Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 10.95 % in forecast period 2025-2032.
  • Indonesia Colorectal Cancer Diagnostics Market to 2032, By End User
    • Hospitals is the largest segment in Indonesia Colorectal Cancer Diagnostics Market to 2032 with a revenue of 11.52 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in Indonesia Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 13.41 % in forecast period 2025-2032.
  • Indonesia Colorectal Cancer Diagnostics Market to 2032, By Product Type
    • Instruments is the largest segment in Indonesia Colorectal Cancer Diagnostics Market to 2032 with a revenue of 24.01 USD Million in the year 2024.
    • Instruments is the Fastest growing segment in Indonesia Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 11.71 % in forecast period 2025-2032.

Indonesia Colorectal Cancer Diagnostics Market Company Share Analysis

 
Company Name Company Share Analysis
Illumina, Inc.
Koninklijke Philips N.V.
Thermo Fisher Scientific Inc.
Quest Diagnostics Incorporated
Bio-Rad Laboratories, Inc.
Indonesia Colorectal Cancer Diagnostics Market Company Share Analysis

Indonesia Colorectal Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

Indonesia Colorectal Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

Indonesia Colorectal Cancer Diagnostics Market Company Profiling

Indonesia Colorectal Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Indonesia Colorectal Cancer Diagnostics Market is segmented based on Segmentation Test Type,Cancer Stages,Cancer Type,Age Group,End User,Product Type.
Indonesia Colorectal Cancer Diagnostics Market was valued at USD 33.68(Revenue in USD Million) in 2021.
Indonesia Colorectal Cancer Diagnostics Market is projected to grow at a CAGR of 10.38% during the forecast period of 2024 to 2032.
The Instruments segment is expected to dominate the Indonesia Colorectal Cancer Diagnostics Market, holding a largest market share of 24.01 USD Million in 2024

Indonesia Colorectal Cancer Diagnostics Market Scope

Indonesia Colorectal Cancer Diagnostics Market Segmentation & Scope
Test Type
  • Others
  • Biopsy
  • Tumor Markers
  • Imaging Test
  • Blood Test
  • Stool Examination
Cancer Stages
  • Stage 0
  • Stage I
  • Stage II
  • Stage IV
  • Stage III
Cancer Type
  • Others
  • Carcinoid Tumors
  • Gastrointestinal Stromal Tumors
  • Colorectal Lymphoma
  • Adenocarcinoma
Age Group
  • Pediatric
  • Adults
  • Geriatric
End User
  • Others
  • Academic Institutes
  • Ambulatory Surgical Centers
  • Cancer Research Centers
  • Diagnostic Centers
  • Hospitals
Product Type
  • Consumables & Accessories
  • Instruments
Frequently Asked Questions
The Indonesia Colorectal Cancer Diagnostics Market is segmented based on Segmentation Test Type,Cancer Stages,Cancer Type,Age Group,End User,Product Type.
Indonesia Colorectal Cancer Diagnostics Market was valued at USD 33.68(Revenue in USD Million) in 2021.
Indonesia Colorectal Cancer Diagnostics Market is projected to grow at a CAGR of 10.38% during the forecast period of 2024 to 2032.
The estimated market value of the Indonesia Colorectal Cancer Diagnostics Market for final year is USD 58.66 (USD Million).

Indonesia Colorectal Cancer Diagnostics Market Company Profiling

Indonesia Colorectal Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Indonesia Colorectal Cancer Diagnostics Market is segmented based on Segmentation Test Type,Cancer Stages,Cancer Type,Age Group,End User,Product Type.
Indonesia Colorectal Cancer Diagnostics Market was valued at USD 33.68(Revenue in USD Million) in 2021.
Indonesia Colorectal Cancer Diagnostics Market is projected to grow at a CAGR of 10.38% during the forecast period of 2024 to 2032.
The estimated market value of the Indonesia Colorectal Cancer Diagnostics Market for final year is USD 58.66 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.